Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlfaEx: GLP-1 Role in Acarbose Effect
NCT03241303Completed
- Sponsor
- Gentofte Hospital
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acarbose with Placebo (2 arms). Primary endpoint: Plasma glucose. Started Aug 2017; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03241303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241303.